With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now producing increasingly personalised and sophisticated therapies, ...

Truong Gia Binh, chairman of FPT Corporation, which has ventured into the pharmaceutical sector, noted that AI is poised to make a significant impact on the industry, especially in the development of ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its ...

In this article, we are going to take a look at where Recursion Pharmaceuticals (NASDAQ:RXRX) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped ...

Though the United States is the global leader in designing chips, the vast majority of chip production happens overseas, ...

Digital tools, powered by intuitive design, AI, and customer centricity, offer a unique opportunity to bridge the trust gap ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

The US Food and Drug Administration (FDA) recently issued its draft guidance, Considerations for the Use of Artificial Intelligence to ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.